Clineschmidt BV[au] - Search Results

Year	Number of Results
1966	1
1969	3
1970	2
1971	3
1972	1
1973	3
1974	2
1975	4
1976	3
1977	5
1978	6
1979	3
1980	4
1982	5
1983	3
1984	2
1985	2
1986	3
1987	4
1988	1
1989	2
1990	2
1991	4
1992	2
1993	2
1994	2
1995	1
1996	1
2022	0

1

Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadine.

Clineschmidt BV, Hanson HM, McGuffin JC, Lotti VJ, Scriabine A, Stone CA. Clineschmidt BV, et al. Arch Int Pharmacodyn Ther. 1976 Oct;223(2):287-300. Arch Int Pharmacodyn Ther. 1976. PMID: 11758

2

Fenfluramine and brain serotonin.

Clineschmidt BV, Zacchei AG, Totaro JA, Pflueger AB, McGuffin JC, Wishousky TI. Clineschmidt BV, et al. Ann N Y Acad Sci. 1978 Jun 12;305:222-41. doi: 10.1111/j.1749-6632.1978.tb31526.x. Ann N Y Acad Sci. 1978. PMID: 309298 No abstract available.

3

The blockade of bulbospinal inhibition by 5-hydroxytryptamine antagonists.

Clineschmidt BV, Anderson EG. Clineschmidt BV, et al. Exp Brain Res. 1970;11(2):175-86. doi: 10.1007/BF00234321. Exp Brain Res. 1970. PMID: 5472271 No abstract available.

4

A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.

Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J. Clineschmidt BV, et al. J Pharmacol Exp Ther. 1988 Apr;245(1):32-40. J Pharmacol Exp Ther. 1988. PMID: 2896239

5

Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine.

Remy DC, Rittle KE, Hunt CA, Anderson PS, Arison BH, Engelhardt EL, Hirschmann R, Clineschmidt BV, Lotti VJ, Bunting PR, Ballentine RJ, Papp NL, Flataker L, Witoslawski JJ, Stone CA. Remy DC, et al. Among authors: clineschmidt bv. J Med Chem. 1977 Aug;20(8):1013-9. doi: 10.1021/jm00218a005. J Med Chem. 1977. PMID: 19627

6

Famotidine: an appraisal of its mode of action and safety.

Berlin RG, Clineschmidt BV, Majka JA. Berlin RG, et al. Among authors: clineschmidt bv. Am J Med. 1986 Oct 24;81(4B):8-12. doi: 10.1016/0002-9343(86)90594-2. Am J Med. 1986. PMID: 2877577

7

Identification of an orally active, nonpeptidyl oxytocin antagonist.

Pettibone DJ, Clineschmidt BV, Kishel MT, Lis EV, Reiss DR, Woyden CJ, Evans BE, Freidinger RM, Veber DF, Cook MJ, et al. Pettibone DJ, et al. Among authors: clineschmidt bv. J Pharmacol Exp Ther. 1993 Jan;264(1):308-14. J Pharmacol Exp Ther. 1993. PMID: 8423533

8

Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications.

Freidinger RM, Williams PD, Tung RD, Bock MG, Pettibone DJ, Clineschmidt BV, DiPardo RM, Erb JM, Garsky VM, Gould NP, et al. Freidinger RM, et al. Among authors: clineschmidt bv. J Med Chem. 1990 Jul;33(7):1843-5. doi: 10.1021/jm00169a001. J Med Chem. 1990. PMID: 2163451 No abstract available.

9

A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212).

Clineschmidt BV, McGuffin JC, Pflueger AB, Totaro JA. Clineschmidt BV, et al. Br J Pharmacol. 1978 Apr;62(4):579-89. doi: 10.1111/j.1476-5381.1978.tb07765.x. Br J Pharmacol. 1978. PMID: 656703 Free PMC article.

10

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

Williams PD, Clineschmidt BV, Erb JM, Freidinger RM, Guidotti MT, Lis EV, Pawluczyk JM, Pettibone DJ, Reiss DR, Veber DF, et al. Williams PD, et al. Among authors: clineschmidt bv. J Med Chem. 1995 Nov 10;38(23):4634-6. doi: 10.1021/jm00023a002. J Med Chem. 1995. PMID: 7473590 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results